Sell these January Target calls for a terrific gain. All three of the retail calls from my November recommendation delivered huge double-digit gains. With a pending January expiration and super high investor enthusiasm, I suggest booking this last gain. Read More
Archive
Filter
Sell Gap Inc. (NYSE: GPS). Gap's done a tremendous job at re-igniting sales growth but the current valuation fully reflects that success. Book the 48% gain and look for more trades with this name in the future. Read More
Drug stocks should be a healthy group in 2018. These three generate positive cash flow and have robust growth in their lead products. I expect pricing pressure from PBMs to muffle a bit as CVS and Aetna focus on getting their merger past the regulators. Read More
Stick with the Chemours Company as trends in its lead products remain strong. A downgrade by Goldman Sachs didn't sway my thesis on the stock. Smart Sand got a boost from another analyst and keep your eyes peeled for more trade alerts coming soon. Read More
Sell to close the March calls on Air Transport for a 61% gain in five trading days. Read More
The Chemours Company wows investors with strong guidance and a remarkable dividend increase at its December 1 analysts' day and Ichor Systems gets dragged down with the chip stocks based on an analyst downgrade. Read More
Buy Air Transport Services Group. This operator and lessor of cargo planes counts Amazon as a big customer and is a solid play on the explosion of e-commerce. Read More
ANI Pharmaceutical delivered a round of holiday cheer due to new rumors of a possible acquisition. Find out what gave investors additional confidence in the name and why Ichor Systems drooped a bit last week. Read More
Profit Catalyst Alert subscribers came out on top after a wild ride in some of our retail names. I remain bullish on the group as we enter the holiday frenzy. Ichor's top customers are growing by leaps and bounds; a good sign for the materials supplier. Read More